Pancreas transplantation using type I and type II spontaneously diabetic rats--our experimental experience. 2007

Toshinori Ito, and Kazunori Shimada, and Miao Gang, and Fumihiro Uchikoshi, and Masayuki Tori, and Hiroshi Komoda, and Yuichi Fumimoto, and Ken Ohmori, and Koichi Kawamoto, and Masahiro Tanemura, and Masumi Nozawa
Department of Complementary and Alternative Medicine, Osaka University Graduate School of Medicine, Osaka, Japan. juki@CAM.med.osaka-u.ac.jp

Pancreas transplantation (PTx) is the only therapy that can cure type 1 diabetes mellitus. With the recent advance of surgical procedures and immunosuppression, the outcome of PTx has become better than it used to be before, but some problems still remain. It is rather difficult to induce tolerance and to reverse rejection once it occurred because pancreas graft itself has a strong immunogenicity. Another important issue is regarding the recurrence of autoimmune disease in the pancreatic graft, therefore, some animal models are necessary to delineate and regulate those immune responses specific for PTx. Recently, PTx is also clinically applicable for type 2 diabetic patients with end-stage renal disease. It has been shown that insulin resistance was improved by PTx in type 2 diabetic recipients. In the current study, we have introduced some useful type 1 and type 2 diabetic models mainly based on our experimental experiences.

UI MeSH Term Description Entries
D007515 Islets of Langerhans Irregular microscopic structures consisting of cords of endocrine cells that are scattered throughout the PANCREAS among the exocrine acini. Each islet is surrounded by connective tissue fibers and penetrated by a network of capillaries. There are four major cell types. The most abundant beta cells (50-80%) secrete INSULIN. Alpha cells (5-20%) secrete GLUCAGON. PP cells (10-35%) secrete PANCREATIC POLYPEPTIDE. Delta cells (~5%) secrete SOMATOSTATIN. Islands of Langerhans,Islet Cells,Nesidioblasts,Pancreas, Endocrine,Pancreatic Islets,Cell, Islet,Cells, Islet,Endocrine Pancreas,Islet Cell,Islet, Pancreatic,Islets, Pancreatic,Langerhans Islands,Langerhans Islets,Nesidioblast,Pancreatic Islet
D011913 Rats, Inbred BB A strain of Rattus norvegicus which is a model for spontaneous insulin-dependent diabetes mellitus (DIABETES MELLITUS, INSULIN-DEPENDENT). BB Wistar Rats,Bio-Breeding Inbred Rats,Rats, BB,BB Rat,BB Rat, Inbred,BB Rats,BB Rats, Inbred,Bio Breeding Inbred Rats,Bio-Breeding Inbred Rat,Inbred BB Rat,Inbred BB Rats,Inbred Rat, Bio-Breeding,Inbred Rats, Bio-Breeding,Rat, BB,Rat, Bio-Breeding Inbred,Rat, Inbred BB,Rats, BB Wistar,Rats, Bio-Breeding Inbred,Wistar Rats, BB
D011922 Rats, Mutant Strains Rats bearing mutant genes which are phenotypically expressed in the animals. Mutant Strains Rat,Mutant Strains Rats,Rat, Mutant Strains,Strains Rat, Mutant,Strains Rats, Mutant
D012038 Regeneration The physiological renewal, repair, or replacement of tissue. Endogenous Regeneration,Regeneration, Endogenous,Regenerations
D003922 Diabetes Mellitus, Type 1 A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. Diabetes Mellitus, Brittle,Diabetes Mellitus, Insulin-Dependent,Diabetes Mellitus, Juvenile-Onset,Diabetes Mellitus, Ketosis-Prone,Diabetes Mellitus, Sudden-Onset,Diabetes, Autoimmune,IDDM,Autoimmune Diabetes,Diabetes Mellitus, Insulin-Dependent, 1,Diabetes Mellitus, Type I,Insulin-Dependent Diabetes Mellitus 1,Juvenile-Onset Diabetes,Type 1 Diabetes,Type 1 Diabetes Mellitus,Brittle Diabetes Mellitus,Diabetes Mellitus, Insulin Dependent,Diabetes Mellitus, Juvenile Onset,Diabetes Mellitus, Ketosis Prone,Diabetes Mellitus, Sudden Onset,Diabetes, Juvenile-Onset,Diabetes, Type 1,Insulin Dependent Diabetes Mellitus 1,Insulin-Dependent Diabetes Mellitus,Juvenile Onset Diabetes,Juvenile-Onset Diabetes Mellitus,Ketosis-Prone Diabetes Mellitus,Sudden-Onset Diabetes Mellitus
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005240 Feasibility Studies Studies to determine the advantages or disadvantages, practicability, or capability of accomplishing a projected plan, study, or project. Feasibility Study,Studies, Feasibility,Study, Feasibility
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D005951 Glucose Tolerance Test A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg). Intravenous Glucose Tolerance,Intravenous Glucose Tolerance Test,OGTT,Oral Glucose Tolerance,Oral Glucose Tolerance Test,Glucose Tolerance Tests,Glucose Tolerance, Oral

Related Publications

Toshinori Ito, and Kazunori Shimada, and Miao Gang, and Fumihiro Uchikoshi, and Masayuki Tori, and Hiroshi Komoda, and Yuichi Fumimoto, and Ken Ohmori, and Koichi Kawamoto, and Masahiro Tanemura, and Masumi Nozawa
December 1990, Fortschritte der Medizin,
Toshinori Ito, and Kazunori Shimada, and Miao Gang, and Fumihiro Uchikoshi, and Masayuki Tori, and Hiroshi Komoda, and Yuichi Fumimoto, and Ken Ohmori, and Koichi Kawamoto, and Masahiro Tanemura, and Masumi Nozawa
July 2003, Pancreas,
Toshinori Ito, and Kazunori Shimada, and Miao Gang, and Fumihiro Uchikoshi, and Masayuki Tori, and Hiroshi Komoda, and Yuichi Fumimoto, and Ken Ohmori, and Koichi Kawamoto, and Masahiro Tanemura, and Masumi Nozawa
August 1988, Surgery,
Toshinori Ito, and Kazunori Shimada, and Miao Gang, and Fumihiro Uchikoshi, and Masayuki Tori, and Hiroshi Komoda, and Yuichi Fumimoto, and Ken Ohmori, and Koichi Kawamoto, and Masahiro Tanemura, and Masumi Nozawa
January 1975, Annali italiani di chirurgia,
Toshinori Ito, and Kazunori Shimada, and Miao Gang, and Fumihiro Uchikoshi, and Masayuki Tori, and Hiroshi Komoda, and Yuichi Fumimoto, and Ken Ohmori, and Koichi Kawamoto, and Masahiro Tanemura, and Masumi Nozawa
March 1981, Transplantation proceedings,
Toshinori Ito, and Kazunori Shimada, and Miao Gang, and Fumihiro Uchikoshi, and Masayuki Tori, and Hiroshi Komoda, and Yuichi Fumimoto, and Ken Ohmori, and Koichi Kawamoto, and Masahiro Tanemura, and Masumi Nozawa
November 1991, Diabetes care,
Toshinori Ito, and Kazunori Shimada, and Miao Gang, and Fumihiro Uchikoshi, and Masayuki Tori, and Hiroshi Komoda, and Yuichi Fumimoto, and Ken Ohmori, and Koichi Kawamoto, and Masahiro Tanemura, and Masumi Nozawa
January 1986, Zeitschrift fur experimentelle Chirurgie, Transplantation, und kunstliche Organe : Organ der Sektion Experimentelle Chirurgie der Gesellschaft fur Chirurgie der DDR,
Toshinori Ito, and Kazunori Shimada, and Miao Gang, and Fumihiro Uchikoshi, and Masayuki Tori, and Hiroshi Komoda, and Yuichi Fumimoto, and Ken Ohmori, and Koichi Kawamoto, and Masahiro Tanemura, and Masumi Nozawa
January 2019, Pakistan journal of medical sciences,
Toshinori Ito, and Kazunori Shimada, and Miao Gang, and Fumihiro Uchikoshi, and Masayuki Tori, and Hiroshi Komoda, and Yuichi Fumimoto, and Ken Ohmori, and Koichi Kawamoto, and Masahiro Tanemura, and Masumi Nozawa
March 1981, Diabetologia,
Toshinori Ito, and Kazunori Shimada, and Miao Gang, and Fumihiro Uchikoshi, and Masayuki Tori, and Hiroshi Komoda, and Yuichi Fumimoto, and Ken Ohmori, and Koichi Kawamoto, and Masahiro Tanemura, and Masumi Nozawa
June 1992, Transplantation proceedings,
Copied contents to your clipboard!